{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:07:39Z","timestamp":1791198459808,"version":"4.1.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLIN INFECT DIS"],"published-print":{"date-parts":[[2002,5]]},"DOI":"10.1086\/339551","type":"journal-article","created":{"date-parts":[[2002,9,30]],"date-time":"2002-09-30T17:28:16Z","timestamp":1033406896000},"page":"1243-1250","source":"Crossref","is-referenced-by-count":102,"title":["Randomized Phase II Trial of Atovaquone with Pyrimethamine or Sulfadiazine for Treatment of Toxoplasmic Encephalitis in Patients with Acquired Immunodeficiency Syndrome: ACTG 237\/ANRS 039 Study"],"prefix":"10.1093","volume":"34","author":[{"given":"Keith","family":"Chirgwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Leport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Remington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Bosler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemente","family":"Roque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Rajicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"McAuliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Morlat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. T.","family":"Jayaweera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Louis","family":"Vilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Luft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the AIDS Clinical Trials Group 237\/Agence Nationale de Recherche sur le SIDA, Essai 039 Study Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"rf1_499","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/clinids\/15.2.211","volume":"15","author":"Luft BJ","year":"1992","journal-title":"Clin Infect Dis"},{"key":"rf2_500","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-116-1-33","volume":"116","author":"Danneman B","year":"1992","journal-title":"Ann Intern Med"},{"key":"rf3_501","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/clinids\/22.2.268","volume":"22","author":"Katlama C","year":"1996","journal-title":"Clin Infect Dis"},{"key":"rf4_502","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291403"},{"key":"rf5_503","doi-asserted-by":"publisher","DOI":"10.1007\/BF02000407"},{"key":"rf6_504","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1128\/AAC.35.10.2049","volume":"35","author":"Fernandez-Martin J","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"rf7_505","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1128\/AAC.39.1.276","volume":"39","author":"Lacassin F","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"rf8_506","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/00365549309169687","volume":"25","author":"Hagberg L","year":"1993","journal-title":"Scand J Infect Dis"},{"key":"rf9_507","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200103300-00007"},{"key":"rf10_508","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199305273282103"},{"key":"rf11_509","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812243392604"},{"key":"rf12_510","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/AAC.35.2.293","volume":"35","author":"Araujo FG","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"rf13_511","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/infdis\/167.2.494","volume":"167","author":"Araujo FG","year":"1993","journal-title":"J Infect Dis"},{"key":"rf14_512","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92172-C"},{"key":"rf15_513","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/clinids\/24.3.422","volume":"24","author":"Torres RA","year":"1997","journal-title":"Clin Infect Dis"},{"key":"rf16_514","first-page":"1107","volume":"10","author":"Katalama C","year":"1996","journal-title":"AIDS"},{"key":"rf17_515","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/AAC.40.3.556","volume":"40","author":"Dixon R","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"rf18_516","doi-asserted-by":"publisher","DOI":"10.1592\/phco.19.13.1050.31598"},{"key":"rf19_517","first-page":"1","volume":"41","author":"Centers","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"rf20_518","doi-asserted-by":"publisher","DOI":"10.1007\/s100960050436"},{"key":"rf21_519","unstructured":"Miro JM, Lopez JC, Podzamczer D, etal Discontinuation of toxoplasmic encephalitis prophylaxis is safe in HIV-1- and T. gondii-co-infected patients after immunological recovery with HAART: preliminary results of the GESIDA 04\/98-B study [abstract 230]. In: Program and abstracts of the 7th Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, VA: Foundation for Retrovirology and Human Health, 2000:119."},{"key":"rf22_520","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1128\/AAC.41.6.1319","volume":"41","author":"Rolan PE","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"rf23_521","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90019-3"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/34\/9\/1243\/5867373\/34-9-1243.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T16:28:59Z","timestamp":1514996939000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1086\/339551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["10.1086\/339551"],"URL":"https:\/\/doi.org\/10.1086\/339551","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}